Saturday, January 29, 2011
Lancet (abstract) Retraction: validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial
Note: full details available to subscribers ($$$)
Comment
Retraction—validation of gene signatures that predict the response of
breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC
10994/BIG 00-01 clinical trial
abstract: Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma?
Objective
Conservative surgery followed by platinum-based chemotherapy is considered the standard approach for pure ovarian dysgerminoma (POD), except for correctly staged IA patients. The aim of study was to evaluate the outcome of IA POD patients with incomplete surgical staging in order to define the proper management.
Subscribe to:
Posts
(
Atom
)
Posts
